Organization | Ilam University of Medical Sciences

Ilam University of Medical Sciences Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial

2016

NCT02711176

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2018

Timeline

NOW

Now

Alternative names

Assistant Professor, Ilam University of Medical Sciences,Head of Faculty of Medicine | Ilam University of Medical Sciences

Active Ingredients

Drugs in Phase 4 Trials (7)

amoxicillin (1 trial)

clarithromycin (biaxin) (1 trial)

esomeprazole (nexium) (1 trial)

ketorolac (acuvail) (1 trial)

lansoprazole (prevacid) (1 trial)

levofloxacin (levaquin) (1 trial)

tinidazole (tindamax) (1 trial)

Drugs in Other Trials (1)

vitamin c (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Communicable Diseases (Phase 4)

Helicobacter Infections (Phase 4)

Infections (Phase 4)

Pancreatitis (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 3
# of Trial APIs: 8